Eli Lilly nears deal for Ventyx Biosciences at $14/share
Digest more
The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...
Shortly after securing a partnership with Sanofi, InduPro is linking up with Eli Lilly in efforts to discover new cancer ...
Evangeline Lilly says 'almost every area in [her] brain is functioning at a decreased capacity' after suffering a concussion ...
Evangeline Lilly didn’t ease into 2026 with a vague caption or a polished PR statement. Instead, the Lost and Marvel star sat ...
Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly to ...
Evangeline Lilly says 'almost every area in my brain is functioning at a decreased capacity' after suffering a concussion ...
Journalism for the people is more important than ever and members help fund journalism that holds leaders accountable and ...
Evangeline Lilly says she has brain damage, months after fainting and hitting her head on a rock while at the beach.
Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback